Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs Long Duration DAPT in Lower Extremity Endovascular Revascularization
NCT02433587Phase 3Withdrawn
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Oct 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in Peripheral Arterial Disease (PAD), sponsored by University Hospitals Cleveland Medical Center. Planned start Oct 2019; status: withdrawn.
02
Drugs
clopidogrel
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02433587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433587.